CClinicalTrials.gg
Enrolling by invitationNCT07262086Updated Dec 22, 2025

Clinical Evaluation of Wear Resistance and Bioactivity of Self Cured Bioactive Resin Composite

An interventional study of Resins, Composite nanohybrid and Resins, Composite bioactive in Dental Caries and Class II Dental Caries, sponsored by Suez Canal University. Enrolling by invitation at 1 site in Egypt. Open to participants aged 21 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-22.

Sponsored by Suez Canal University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
21 Years to 45 Years
Sex
All
01

Study summary

Introduction:

Resin-based composites (RBCs) have become the gold standard in restorative dentistry due to their superior aesthetics, adhesion, and minimally invasive application. However, wear remains a critical drawback, compromising their longevity and clinical performance. Various techniques have been suggested to measure the clinical performance of (RBCs). Recent advancements in digital dentistry, such as intraoral scanning, offer a more precise and efficient approach for quantitative wear assessment.

Aim:

This study aims to evaluate wear resistance and bioactivity of self cured bioactive resin composite vs nanhybrid resin composite.

Methodology:

Twelve healthy patients with 24 carious molar teeth will be selected where each patient should have two oclusso- mesial cavities. Standardized oclusso- mesial cavities will be prepared for all the selected teeth, for each patient the first tooth will be restored with conventional nanohybrid RBC (M1). Meanwhile, the second tooth will be restored by self-cure bioactive RBC (M2). Then, wear resistance will be evaluated by intraoral scanner immediately after restoration (T0), six months later (T1), after 12 months (T2), 18 months (T3) and 24 months (T4). Software analysis will be done by superimposing the 3D digital impression and evaluate the restoration wear by calculating the 3D volume loss.

Also, bioactivity of the restoration will be measured by measuring the mineral density beneath the restoration. Digital radiographic images will be taken for the restoration by parallel technique and grey scale of the pixels under restoration will be measured by software immediately after restoration (D0), one month later (D1) and after 3 months (D2).

Read the detailed description

II- 1 Study Setting:

A randomized controlled double-blinded clinical trial will be conducted where both patient and examiners will be blinded to the group assignment. Patients of age group 21-45 years will be selected where each patient should have two oclusso- mesial cavities. Patients will be recruited from the outpatient clinic of Conservative Dentistry department in the Faculty of Dentistry, Suez Canal University. During the initial examination, the purpose and the method of the research will be explained to the patients and a written informed consent will be assigned by each individual.

II-2 Sample Selection:

Patients participating in this study will be selected according to the following eligibility criteria:

II-2-a Inclusion Criteria:

  1. Patients with vital two molar teeth with compound class II deep carious lesions.
  2. Both males and females will be included.
  3. Patients with good general health.
  4. Patients with good oral hygiene.
  5. Co-operative patients.
  6. Absence of spontaneous pain, mobility or tenderness on percussion.
  7. Radiographically: no internal or external resorption, no periapical or furcation radiolucency and no widening of the periodontal ligament space.

II-2-b Exclusion Criteria:

  1. Patients with systemic decease.
  2. Patients with severe or chronic periodontitis.
  3. Patients have allergy to the materials used in this trial.
  4. Nonfunctioning teeth.
  5. Teeth with any pathologic pulpal changes.
  6. Teeth with previous restorations.
  7. Teeth with surface loss due to non carious lesions. All patients who will attend the clinic will receive the proposed treatment protocols. However, only those who will meet the inclusion criteria will be enrolled in the study and included in the trial. Patients who will not fulfill the inclusion criteria will also be treated but will be excluded from the study analysis.

II-3 Cavity preparation:

The same treatment protocol will be followed for all patients where each patient will receive two compound class II cavities in posterior molar teeth distributed in both sides. Local anesthesia will be administered in the beginning of the session and quadrant isolation will be administrated by rubber dam. Access through enamel and outline form will be obtained with a sterile high speed #245 bur. Following the international guidelines, all soft infected dentine will be removed, and a hard sound dentin floor should be reached. For the peripheries of the cavity, carious tissue removal to hard dentine will be performed using a sharp sterile spoon double-ended excavator and a low-speed round bur. The dentinoenamel junction, cavosurface margins and gingival box will be inspected carefully and to be clean, with at least 1.5 to 2 mm rim of peripheral sound tooth structure to provide a firm marginal adhesion for the restoration.

II-4 Randomization:

To minimize selection bias and ensure equal distribution of treatment protocol across both treated molars, simple randomization will be used to randomly determine which molar receives which material. Therefore, randomization will be performed using an online randomization tool (https://www.randomizer.org/) prior to treatment allocation where, each patient will be given a unique study number, ensuring that each patient receives both treatments in a randomly assigned manner.

II-5 Restorative procedures:

Each included patient with the already prepared cavities will receive two different types of restorations. where one of them will be restored with light cured nano hybrid RBC (Filtek™ Z250, 3M ESPE St.Paul,M,USA) (M1) meanwhile, the second cavity will be restored with self-cure bioactive RBC (Stela, SDI, Australia) (M2).

A sectional matrix system will be used to achieve proper proximal contour and anatomically correct contact with the adjacent tooth. Then, the restorative procedure of each cavity will be carried out according to the manufacturer's recommendations of each tested restoration. Before restoration each cavity will be carefully cleaned with copious air water spray before being dried. Restoration of (M1) group will be performed through selective etching of the prepared cavity enamel surface using 37% phosphoric acid gel (Meta Biomed, Korea) for 15 seconds. This will be followed by rinsing with water for 15 seconds and gentle air drying for 5 seconds, leaving the cavity slightly moist. After that, single layer of a universal adhesive bonding agent (Bisco, INC Schaumburg, IL, USA) will be applied to the prepared cavity walls and floor using disposable adhesive micro brush. The adhesive will be subsequently cured for 20 seconds using LED light curing unit (Elipar S10, 3M ESPE, St Paul, Minnesota, USA) with an intensity of 1200 mW/cm2. The nano hybrid RBC (Filtek™ Z250) will be incrementally applied, and light cured according to manufacturer instructions. Finally, finishing and polishing of the restoration using one-step polishing system (Dimanto, Voco, Germany). Then, checking of occlusion and proximal contacts will be done.

Restoration of (M2) group will be performed through conditioning of cavities with a specialized primer (STELA primer, SDI, Australia) according to manufacturer instructions. Then, a self cured bioactive RBC (STELA, SDI, Australia) will be placed in a single increment and allowed to self-cure according to manufacturer instructions. Then, finishing and polishing of the restoration, checking the occlusion and proximal contacts will be done as mentioned before.

II-6- Evaluation of the wear resistance:

A digital impression will be taken immediately after restoration (T0) using an intraoral scanner (Helios 600 intraoral scanner, Eighteeth, Changzhou, China). To ensure optimal performance and accuracy, the scanner underwent regular calibration before scanning each patient, following the manufacturer's recommendations. During the scanning procedure, the device will be positioned at a 90° angle for the occlusal surface and at 45° angles for both buccal and lingual surfaces. Later on, each restoration will be examined at standardized follow-up periods; six months (T1), twelve months (T2), eighteen months (T3) and twenty-four months (T4). The 3D impressions will be analyzed using a software (Geomagic software, 3D Systems Inc., USA) program and the impressions of each two consultative visits will be superimposed to determine the wear volume loss (mm3).

II-7- Assessment of the bioactivity:

Bioactivity of each examined restoration will be determined by the evaluation of mineral density beneath the tested materials. Immediately after restoration (D0), an image plate digital sensor (Xios XG Supreme, Dentsply Sirona, UK) will be used for transmitting the radiographic image of the selected tooth to the computer. A posterior parallel kit will be used for image standardization. Later, each restoration will be examined at standardized follow-up periods; one month (D1) and three months (D2). The image plate will be inserted at one end of the parallel kit, while the other end was connected to the x-ray cone. All the radiographs will be evaluated for the outcome by a software (ImageJ software, NIH, USA). The assessment of mineral density will be done by the software through performing the following measurements: in each image a line will be drawn along the CEJ to act as a reference, while another parallel line will be drawn at the bottom of the cavity. The distance between both lines will be standardized for each tooth by measuring the length of a vertical line connecting them. The length of the line centralized at the bottom of the cavity will be determined in pixels directly via the previously mentioned software. Such length will be fixed for each sample throughout assessment intervals. Three points on this line (at its start, middle and end) will be determined. The mineral density value at each of these points will be identified by taking the corresponding three readings from the software and recording them to calculate the average value. The mineral density mean value will be calculated from the software

02

Conditions studied

  • Dental Caries
  • Class II Dental Caries

Browse trials for

Keywords

  • dental caries
  • wear resistance
  • bioactive resin composite
03

In context

Dental Caries

1,109 studies on the registry are indexed under Dental Caries; 197 are open to participants now.

This study's planned enrollment of 25 is below the median of 60 across 916 interventional studies indexed under Dental Caries.

Browse Dental Caries studies →

Lead sponsor

Suez Canal University is the lead sponsor of 157 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients with vital two molar teeth with compound class II deep carious lesions.
  • Both males and females will be included.
  • Patients with good general health.
  • Patients with good oral hygiene.
  • Co-operative patients.
  • Absence of spontaneous pain, mobility or tenderness on percussion.
  • Radiographically: no internal or external resorption, no periapical or furcation radiolucency and no widening of the periodontal ligament space.

Exclusion criteria

Exclusion Criteria:

  • Patients with systemic disease.
  • Patients with severe or chronic periodontitis.
  • Patients having allergy to the materials used in this trial.
  • Nonfunctioning teeth.
  • Teeth with any pathologic pulpal changes.
  • Teeth with previous restorations.
  • Teeth with surface loss due to non carious lesions.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
25 participants (estimated)

Study arms

  • Sham comparator
    Light cured nanohybrid RBC restorations

    Conventional nanohybrid composite placement for Class II restorations

    Procedure: Resins, Composite nanohybrid

  • Experimental
    "Self-cured Bioactive Resin Composite."

    Self-cured bioactive composite placement for Class II restorations

    Procedure: Resins, Composite bioactive

Interventions

  • ProcedureResins, Composite nanohybrid

    Placement of light-cured nanohybrid resin composite for Class II restorations, following manufacturer's instructions

    Also known as: conventional nanohybrid resin composite

  • ProcedureResins, Composite bioactive

    Placement of self-cured bioactive resin composite for Class II restorations, following manufacturer's instructions

    Also known as: bioactive composite

06

What researchers measure

Primary outcomes

  1. Assessment of the bioactivity

    Bioactivity of each examined restoration will be determined by the evaluation of mineral density beneath the tested materials. Immediately after restoration (D0), an image plate digital sensor (Xios XG Supreme, Dentsply Sirona, UK) will be used for transmitting the radiographic image of the selected tooth to the computer. Later, each restoration will be examined at standardized follow-up periods. All the radiographs will be evaluated for the outcome by a software (ImageJ software, NIH, USA).

    Time frame: immediately after restoration (D0) ; one month (D1) and three months (D2)

  2. wear resistance

    A digital impression will be taken immediately after restoration (T0) using an intraoral scanner (Helios 600 intraoral scanner, Eighteeth, Changzhou, China). To ensure optimal performance and accuracy, the scanner underwent regular calibration before scanning each patient, following the manufacturer's recommendations. During the scanning procedure, the device will be positioned at a 90° angle for the occlusal surface and at 45° angles for both buccal and lingual surfaces. Later on, each restoration will be examined at standardized follow-up periods; six months (T1), twelve months (T2), eighteen months (T3) and twenty-four months (T4). The 3D impressions will be analyzed using a software (Geomagic software, 3D Systems Inc., USA) program and the impressions of each two consultative visits will be superimposed to determine the wear volume loss (mm3)

    Time frame: Immediately after restoration, six months (T1), twelve months (T2), eighteen months (T3) and twenty-four months (T4).

07

Study locations

1 site
  • Suez Canal University
    Ismailia, Ismalia, Egypt
08

References and documents

Publications

  • Elderiny HM, Khallaf YS, Akah MM, Hassanein OE. Clinical Evaluation of Bioactive Injectable Resin Composite vs Conventional Nanohybrid Composite in Posterior Restorations: An 18-Month Randomized Controlled Clinical Trial. J Contemp Dent Pract. 2024 Aug 1;25(8):794-802. doi: 10.5005/jp-journals-10024-3737. PubMed 39653674 ↗

Study documents

  • Study protocol · Oct 7, 2025

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — international puplication

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07262086
Lead sponsor
Suez Canal University
Responsible party
Sponsor
First posted
Dec 3, 2025
Start date
Nov 22, 2025
Primary completion
Dec 2, 2026 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
Dec 22, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion